$0.41 Earnings Per Share Expected for Phibro Animal Health Corp (PAHC) This Quarter

Wall Street analysts expect that Phibro Animal Health Corp (NASDAQ:PAHC) will post earnings of $0.41 per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Phibro Animal Health’s earnings, with estimates ranging from $0.40 to $0.43. Phibro Animal Health reported earnings per share of $0.37 during the same quarter last year, which suggests a positive year over year growth rate of 10.8%. The firm is expected to report its next quarterly earnings results on Monday, May 14th.

According to Zacks, analysts expect that Phibro Animal Health will report full-year earnings of $1.63 per share for the current year, with EPS estimates ranging from $1.56 to $1.70. For the next financial year, analysts forecast that the firm will post earnings of $1.78 per share, with EPS estimates ranging from $1.68 to $1.90. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that follow Phibro Animal Health.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, February 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.38 by $0.06. The firm had revenue of $205.90 million for the quarter, compared to analyst estimates of $194.90 million. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The company’s revenue was up 7.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.39 EPS.

PAHC has been the topic of several recent research reports. Piper Jaffray Companies reiterated a “buy” rating and set a $42.00 price objective on shares of Phibro Animal Health in a research report on Friday, November 10th. Zacks Investment Research upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price objective on the stock in a research report on Tuesday, October 31st. ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th. Credit Suisse Group increased their price objective on Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Thursday, December 21st. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $38.20.

Shares of Phibro Animal Health (NASDAQ PAHC) traded down $1.25 during trading on Thursday, hitting $35.35. The stock had a trading volume of 74,194 shares, compared to its average volume of 77,244. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.85. The company has a market cap of $1,460.65, a price-to-earnings ratio of 23.10, a PEG ratio of 3.97 and a beta of 1.18. Phibro Animal Health has a 12-month low of $26.70 and a 12-month high of $40.25.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, March 7th will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 1.13%. The ex-dividend date is Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio is presently 26.14%.

A number of hedge funds have recently modified their holdings of PAHC. First Manhattan Co. purchased a new stake in Phibro Animal Health during the 4th quarter valued at about $100,000. Dean Capital Investments Management LLC purchased a new stake in Phibro Animal Health during the 4th quarter valued at about $200,000. Susquehanna International Group LLP purchased a new stake in Phibro Animal Health during the 2nd quarter valued at about $219,000. Teacher Retirement System of Texas purchased a new stake in Phibro Animal Health during the 4th quarter valued at about $224,000. Finally, Crossmark Global Holdings Inc. purchased a new stake in Phibro Animal Health during the 4th quarter valued at about $253,000. Institutional investors own 48.31% of the company’s stock.

WARNING: This report was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/08/0-41-earnings-per-share-expected-for-phibro-animal-health-corp-pahc-this-quarter.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Get a free copy of the Zacks research report on Phibro Animal Health (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply